SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-23-097802
Filing Date
2023-04-11
Accepted
2023-04-11 16:08:52
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-11

Document Format Files

Seq Description Document Type Size
1 ARS d266538dars.pdf ARS 2128062
  Complete submission text file 0001193125-23-097802.txt   2932785
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36510 | Film No.: 23813501
SIC: 2834 Pharmaceutical Preparations